A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS
Recruiting · NCT06906471 · Interventional (participants receive a specific treatment) · Lead sponsor: Antelope Surgical Solutions, Inc
View the official record on ClinicalTrials.gov →Interventions studied
AS1986NS
What this trial is about
A Single-Arm, blinded, fluorescent PSMA histopathology trial of AS1986NS
Who can take part
Age range
18 Years to 90 Years
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 1, Phase 2
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- suspected prostate cancer warranting standard of care multi-core prostate biopsy
Exclusion criteria
- Patients receiving same-day therapeutic Lutetium-177 or Actinium-225 PSMA receptor radiation isotope therapy treatment
- Patients with pre-existing, impaired or abnormal hepatic function, renal function, cardiac function, and abnormal elevated temperature
- Patients with a creatinine clearance cutoff (CrCl) of \< 60 mL/min
Where it is running
2 locations listed across 2 US states.
- HCA Florida Kendall Hospital - Miami, Florida, United States
- Icahn School of Medicine at Mount Sinai (ISMMS) - New York, New York, United States